Phase I/II Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy.
Phase of Trial: Phase I/II
Latest Information Update: 04 Jul 2014
At a glance
- Drugs Noscapine (Primary)
- Indications Chronic lymphocytic leukaemia; Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 15 Feb 2008 The expected completion date for this trial is now 1 Dec 2006.
- 14 Jan 2008 Status changed from recruiting to discontinued.
- 22 Oct 2005 New trial record.